BridgeMD
New treatment option for Amputation; Traumatic, Hand
Official title To Assess the Utility of the Point Mini in a Clinical Take-home Study
ClinicalTrials.gov ID: NCT06501092
What this study is testing
- What it's testing
- The objective of this study is to evaluate the efficacy of the Point Mini system as compared to the subject's existing prosthetic treatment, which may include a prosthesis, other assistive device, or no device. This study will be a single subject crossover design where one group of 14 children with partial hand deficiencies will be evaluated on several metrics using their existing prosthetic treatment for one month and the Point Mini system for two months.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 17
You may be able to join if
- Unilateral or bilateral partial hand limb differences
- Fluent in English or Spanish
- Ability to follow simple directions
- Age between 3 and 17 years
You likely can't join if
- Patients with any unhealed wounds on their residual limb(s)
- Significant cognitive deficits as determined upon clinical evaluation
- Inability to follow simple directions
- Significant physical deficits including pain and scarring impacting the design and fitting of the Point Mini prosthesis
- Other psychosocial, personal, and medical co-morbidities expressed by the subject, family or study personnel
The study team makes the final eligibility decision.
Where it's taking place
- Lafayette, Colorado, United States
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lafayette, Colorado, United States; Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.